Vemurafenib in Combination with the MEK inhibitor, GDC-0973 in BRAFV600 Mutation pos Melanoma - 100285

Spotlight
Video

Vemurafenib in Combination with the MEK inhibitor, GDC-0973 in BRAFV600 Mutation pos Melanoma

feeds has 409 videos Subscribe Here

Loading........
Description: Vienna, ESMO 2012, Pressconference September 29: Prof Rene Gonzalez, Division Of Medical Oncology, University of Colorado, Aurora/UNITED STATES OF AMERICA
Phase IB Study of Vemurafenib in Combination with the MEK inhibitor, GDC-0973, in Patients with Locally Advanced/Unresectable or Metastatic BRAFV600 Mutation Positive Melanoma.
Shared By : feeds
Posted on : 10/02/12
Added : 5 years ago



More From feeds

Nothing found.